Abbott Labs Path to Double-Digit Earnings Growth In 2025? This Analyst Is Optimistic

On Wednesday, Abbott Laboratories ABT reported third-quarter sales of $10.64 billion, up 4.9% year over year, beating the consensus of $10.55 billion. Organic sales growth for the underlying base business was 8.2%, led by double-digit growth in Medical Devices. Abbott's adjusted diluted earnings per share was $1.21, beating the analyst estimates of $1.20. Abbott projects full-year 2024 adjusted EPS of $4.64-$4.70 versus prior guidance of $4.61-$4.71 and consensus of $4.66. It forecasts fourth-quarter adjust ...